<?xml version="1.0" ?>
<text author="Marica Meroni, Miriam Longo, Veronica Erconi, Luca Valenti, Stefano Gatti, Anna  Ludovica Fracanzani, Paola Dongiovanni" dateCollected="2019-11-03" id="amalgum_academic_doc466" shortTile="mirp-downregulation" sourceURL="https://www.mdpi.com/2072-6643/11/11/2597/htm" speakerCount="0" speakerList="none" title="mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance" type="academic">
<head>
<s type="frag">
1.	LS	@ord@
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Nonalcoholic	NN	nonalcoholic
fatty	NN	fatty
liver	NN	liver
disease	NN	disease
(	-LRB-	(
NAFLD	NNP	NAFLD
)	-RRB-	)
represents	VBZ	represent
the	DT	the
leading	VBG	lead
cause	NN	cause
of	IN	of
progressive	JJ	progressive
liver	NN	liver
disorders	NNS	disorder
worldwide	JJ	worldwide
,	,	,
affecting	VBG	affect
between	IN	between
20	CD	@card@
%	NN	%
to	TO	to
40	CD	@card@
%	NN	%
of	IN	of
the	DT	the
adult	JJ	adult
population	NN	population
.	.	.
</s>
<s type="decl">
NAFLD	NN	NAFLD
is	VBZ	be
defined	VBN	define
by	IN	by
increased	VBN	increase
hepatic	NN	hepatic
fat	NN	fat
accumulation	NN	accumulation
not	RB	not
explained	VBN	explain
by	IN	by
alcohol	NN	alcohol
abuse	NN	abuse
,	,	,
and	CC	and
it	PRP	it
encompasses	VBZ	encompass
a	DT	a
wide	JJ	wide
spectrum	NN	spectrum
of	IN	of
liver	NN	liver
injuries	NNS	injury
,	,	,
ranging	VBG	range
from	IN	from
simple	JJ	simple
steatosis	NN	steatosis
(	-LRB-	(
&gt;5	CD	&gt;5
%	NN	%
of	IN	of
liver	NN	liver
weight	NN	weight
)	-RRB-	)
to	TO	to
its	PRP$	its
inflammatory	JJ	inflammatory
form	NN	form
nonalcoholic	JJ	nonalcoholic
steatohepatitis	NN	steatohepatitis
(	-LRB-	(
NASH	NNP	NASH
)	-RRB-	)
.	.	.
</s>
<s type="decl">
NASH	NNP	NASH
may	MD	may
be	VB	be
complicated	VBN	complicated
by	IN	by
the	DT	the
presence	NN	presence
of	IN	of
fibrosis	NN	fibrosis
and	CC	and
,	,	,
eventually	RB	eventually
,	,	,
it	PRP	it
may	MD	may
progress	VB	progress
to	TO	to
cirrhosis	NN	cirrhosis
and	CC	and
hepatocellular	NN	hepatocellular
carcinoma	NN	carcinoma
(	-LRB-	(
HCC	NNP	HCC
)	-RRB-	)
.	.	.
</s>
<s type="decl">
NAFLD	NNP	NAFLD
has	VBZ	have
a	DT	a
strong	JJ	strong
inherited	VBN	inherited
component	NN	component
,	,	,
and	CC	and
variants	NNS	variant
in	IN	in
proteins	NNS	protein
regulating	VBG	regulate
hepatocellular	JJ	hepatocellular
lipid	NN	lipid
handling	NN	handle
,	,	,
including	VBG	include
patatin-like	JJ	patatin-like
phospholipase	NN	phospholipase
domain-containing	NN	domain-containing
3	CD	3
(	-LRB-	(
PNPLA3	NNP	PNPLA3
)	-RRB-	)
,	,	,
transmembrane	NN	transmembrane
6	CD	6
superfamily	NN	superfamily
member	NN	member
2	CD	2
(	-LRB-	(
TM6SF2	NNP	TM6SF2
)	-RRB-	)
,	,	,
membrane	NN	membrane
bound	JJ	bind
O-acyltransferase	NNP	O-acyltransferase
domain-containing	NN	domain-containing
7	CD	7
(	-LRB-	(
MBOAT7	NNP	MBOAT7
)	-RRB-	)
,	,	,
predispose	VB	predispose
to	TO	to
the	DT	the
disease	NN	disease
development	NN	development
and	CC	and
progression	NN	progression
to	TO	to
NASH	NNP	NASH
and	CC	and
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
Dietary	NN	Dietary
habits	NNS	habit
such	JJ	such
as	IN	as
excessive	JJ	excessive
caloric	NN	caloric
intake	NN	intake
,	,	,
fructose	NN	fructose
consumption	NN	consumption
,	,	,
and	CC	and
physical	JJ	physical
inactivity	NN	inactivity
represent	VBP	represent
other	JJ	other
risk	NN	risk
factors	NNS	factor
for	IN	for
NAFLD	NNP	NAFLD
development	NN	development
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
its	PRP$	its
pathogenesis	NN	pathogenesis
is	VBZ	be
closely	RB	closely
intertwined	VBN	intertwine
with	IN	with
excessive	JJ	excessive
adiposity	NN	adiposity
,	,	,
insulin	NN	insulin
resistance	NN	resistance
(	-LRB-	(
IR	NNP	IR
)	-RRB-	)
,	,	,
and	CC	and
metabolic	NN	metabolic
syndrome	NN	syndrome
.	.	.
</s>
</p>
<p>
<s type="decl">
IR	NN	IR
even	RB	even
correlates	VBZ	correlate
with	IN	with
the	DT	the
severity	NN	severity
of	IN	of
liver	NN	liver
fibrosis	NN	fibrosis
,	,	,
the	DT	the
main	JJ	main
determinant	NN	determinant
of	IN	of
NAFLD	NNP	NAFLD
prognosis	NN	prognosis
.	.	.
</s>
<s type="decl">
Indeed	RB	indeed
,	,	,
fibrosis	NN	fibrosis
has	VBZ	have
been	VBN	be
observed	VBN	observe
in	IN	in
diabetic	JJ	diabetic
patients	NNS	patient
with	IN	with
NAFLD	NNP	NAFLD
even	RB	even
independently	RB	independently
of	IN	of
NASH	NNP	NASH
,	,	,
and	CC	and
genetic	JJ	genetic
variants	NNS	variant
that	WDT	that
impair	VBP	impair
insulin	NN	insulin
receptor	NN	receptor
(	-LRB-	(
InsR	NNP	insr
)	-RRB-	)
signaling	VBG	signal
favor	VB	favor
fibrosis	NN	fibrosis
development	NN	development
in	IN	in
NAFLD	NNP	NAFLD
patients	NNS	patient
.	.	.
</s>
<s type="sub">
The	DT	the
mechanism	NN	mechanism
whereby	IN	whereby
IR	NNP	IR
aggravates	VBZ	aggravate
fibrosis	NN	fibrosis
may	MD	may
be	VB	be
related	VBN	relate
to	TO	to
reduced	VBN	reduce
extracellular	JJ	extracellular
matrix	NN	matrix
(	-LRB-	(
ECM	NNP	ECM
)	-RRB-	)
degradation	NN	degradation
and	CC	and
to	TO	to
the	DT	the
induction	NN	induction
of	IN	of
proteins	NNS	protein
involved	VBN	involve
in	IN	in
collagen	NN	collagen
crosslinking	NN	crosslinking
.	.	.
</s>
</p>
<p>
<s type="decl">
A	DT	a
new	JJ	new
perspective	NN	perspective
of	IN	of
NAFLD	NNP	NAFLD
pathogenesis	NN	pathogenesis
and	CC	and
management	NN	management
is	VBZ	be
provided	VBN	provide
by	IN	by
epigenetics	NN	epigenetics
,	,	,
which	WDT	which
modulate	VBP	modulate
transcriptome	NN	transcriptome
in	IN	in
response	NN	response
to	TO	to
environmental	JJ	environmental
cues	NNS	cue
.	.	.
</s>
<s type="decl">
In	IN	in
particular	JJ	particular
,	,	,
microRNAs	NNPS	microrna
(	-LRB-	(
miRNAs	NNPS	mirny
)	-RRB-	)
are	VBP	be
short	JJ	short
non-protein	JJ	non-protein
coding	NN	coding
,	,	,
single-strand	JJ	single-strand
RNAs	NNS	rnA
of	IN	of
19	CD	@card@
–	TO	–
22	CD	@card@
nucleotides	NNS	nucleotide
that	WDT	that
regulate	VBP	regulate
gene	NN	gene
expression	NN	expression
and	CC	and
cell-to-cell	JJ	cell-to-cell
communication	NN	communication
as	IN	as
it	PRP	it
occurs	VBZ	occur
between	IN	between
hepatocytes	NNS	hepatocyte
and	CC	and
hepatic	NN	hepatic
stellate	JJ	stellate
cells	NNS	cell
(	-LRB-	(
HSCs	NNP	HSC
)	-RRB-	)
during	IN	during
fibrogenesis	NN	fibrogenesis
.	.	.
</s>
<s type="decl">
Alteration	NN	alteration
of	IN	of
miRNA	NNP	miRNA
expression	NN	expression
in	IN	in
response	NN	response
to	TO	to
genetic/epigenetic	JJ	genetic/epigenetic
factors	NNS	factor
or	CC	or
environmental	JJ	environmental
conditions	NNS	condition
may	MD	may
contribute	VB	contribute
to	TO	to
steatosis	NN	steatosis
onset	NN	onset
and	CC	and
NAFLD	NNP	NAFLD
progression	NN	progression
to	TO	to
fibrosis	NN	fibrosis
and	CC	and
cancer	NN	cancer
,	,	,
mirroring	VBG	mirrore
the	DT	the
histological	JJ	histological
features	NNS	feature
and	CC	and
the	DT	the
molecular	JJ	molecular
events	NNS	event
occurring	VBG	occur
in	IN	in
NAFLD	NNP	NAFLD
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
they	PRP	they
could	MD	could
be	VB	be
exploited	VBN	exploit
as	IN	as
attractive	JJ	attractive
candidate	NN	candidate
biomarkers	NNS	biomarker
for	IN	for
an	DT	an
accurate	JJ	accurate
profiling	NN	profile
of	IN	of
the	DT	the
different	JJ	different
stages	NNS	stage
of	IN	of
liver	NN	liver
injury	NN	injury
,	,	,
enabling	VBG	enable
early	JJ	early
and	CC	and
non-invasive	JJ	non-invasive
diagnosis	NN	diagnosis
and	CC	and
the	DT	the
clinical	JJ	clinical
monitoring	NN	monitoring
of	IN	of
the	DT	the
disease	NN	disease
progression	NN	progression
.	.	.
</s>
</p>
<p>
<s type="decl">
Therefore	RB	therefore
,	,	,
we	PRP	we
aimed	VBD	aim
to	TO	to
explore	VB	explore
the	DT	the
mechanisms	NNS	mechanism
through	IN	through
which	WDT	which
epigenetics	NN	epigenetics
and	CC	and
environmental	JJ	environmental
factors	NNS	factor
interact	VBP	interact
to	TO	to
promote	VB	promote
progressive	JJ	progressive
NAFLD	NNP	NAFLD
in	IN	in
the	DT	the
context	NN	context
of	IN	of
IR	NNP	IR
.	.	.
</s>
<s type="decl">
To	TO	To
this	DT	this
purpose	NN	purpose
,	,	,
we	PRP	we
first	RB	first
assessed	VBD	assess
which	WDT	which
miRNAs	NNPS	mirny
were	VBD	be
deregulated	VBN	deregulate
by	IN	by
IR	NNP	IR
in	IN	in
HSCs	NNP	HSC
whose	WP$	whose
activation	NN	activation
represents	VBZ	represent
the	DT	the
hallmark	NN	hallmark
of	IN	of
liver	NN	liver
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
Secondly	RB	secondly
,	,	,
we	PRP	we
evaluated	VBD	evaluate
whether	IN	whether
the	DT	the
miRNAs	NNPS	mirny
differentially	RB	differentially
expressed	VBD	express
in	IN	in
insulin	NN	insulin
resistant	JJ	resistant
HSCs	NNP	HSC
could	MD	could
impact	VB	impact
on	IN	on
NAFLD-related	JJ	NAFLD-related
fibrosis	NN	fibrosis
by	IN	by
using	VBG	use
an	DT	an
experimental	JJ	experimental
model	NN	model
of	IN	of
IR-NASH	NNP	IR-NASH
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
to	TO	to
investigate	VB	investigate
the	DT	the
independent	JJ	independent
contribution	NN	contribution
of	IN	of
IR	NNP	IR
and	CC	and
NASH	NNP	NASH
that	WDT	that
is	VBZ	be
usually	RB	usually
intertwined	VBN	intertwine
in	IN	in
patients	NNS	patient
on	IN	on
miRNAs	NNP	mirny
expression	NN	expression
,	,	,
IR	NNP	IR
was	VBD	be
induced	VBN	induce
in	IN	in
mice	NNS	mice
by	IN	by
haploinsufficiency	NN	haploinsufficiency
for	IN	for
InsR	NNP	insr
(	-LRB-	(
InsR+/−	NNP	insr+/−
)	-RRB-	)
,	,	,
which	WDT	which
determines	VBZ	determine
an	DT	an
impairment	NN	impairment
of	IN	of
hepatic	NN	hepatic
insulin	NN	insulin
signaling	VBG	signal
recapitulating	VBG	recapitulate
that	WDT	that
has	VBZ	have
been	VBN	be
observed	VBN	observe
in	IN	in
NAFLD	NNP	NAFLD
patients	NNS	patient
.	.	.
</s>
<s type="decl">
Conversely	RB	Conversely
,	,	,
to	TO	to
model	NN	model
fibrogenic	JJ	fibrogenic
NASH	NNP	NASH
,	,	,
we	PRP	we
exploited	VBD	exploit
the	DT	the
methionine	NN	methionine
choline	NN	choline
deficient	JJ	deficient
(	-LRB-	(
MCD	NNP	MCD
)	-RRB-	)
diet	NN	diet
,	,	,
which	WDT	which
impairs	VBZ	impair
phospholipid	JJ	phospholipid
metabolism	NN	metabolism
without	IN	without
altering	VBG	alter
IR	NNP	IR
.	.	.
</s>
<s type="decl">
Finally	RB	finally
,	,	,
we	PRP	we
tested	VBD	tested
the	DT	the
expression	NN	expression
of	IN	of
the	DT	the
candidate	NN	candidate
miRNAs	NNPS	mirny
in	IN	in
immortalized	VBN	immortalize
human	JJ	human
hepatoma	NN	hepatoma
cells	NNS	cell
(	-LRB-	(
HepG2	NNP	HepG2
)	-RRB-	)
and	CC	and
in	IN	in
HSCs	NNP	HSC
(	-LRB-	(
LX-2	NNP	LX-2
)	-RRB-	)
in	IN	in
the	DT	the
presence	NN	presence
or	CC	or
absence	NN	absence
of	IN	of
miRNA	NNP	miRNA
mimics	VBZ	mimic
.	.	.
</s>
<s type="decl">
Here	RB	here
,	,	,
we	PRP	we
showed	VBD	show
that	IN	that
miR-101-3p	CD	miR-101-3p
was	VBD	be
downregulated	VBN	downregulated
in	IN	in
InsR+/−	NNP	insr+/−
HSCs	NNP	HSC
and	CC	and
hepatocytes	NNS	hepatocyte
,	,	,
its	PRP$	its
expression	NN	expression
was	VBD	be
reduced	VBN	reduce
even	RB	even
in	IN	in
total	JJ	total
livers	NNS	liver
of	IN	of
insulin	NN	insulin
resistant	JJ	resistant
mice	NNS	mice
,	,	,
and	CC	and
it	PRP	it
was	VBD	be
associated	VBN	associate
with	IN	with
all	DT	all
stages	NNS	stage
of	IN	of
liver	NN	liver
disease	NN	disease
.	.	.
</s>
</p>
<p>
<s type="decl">
Consistently	RB	consistently
with	IN	with
these	DT	these
results	NNS	result
,	,	,
target	VBP	target
prediction	NN	prediction
analysis	NN	analysis
revealed	VBN	reveal
that	IN	that
miR-101-3p	CD	miR-101-3p
is	VBZ	be
involved	VBN	involve
in	IN	in
insulin	NN	insulin
signaling	NN	signal
,	,	,
lipid	NN	lipid
metabolism	NN	metabolism
,	,	,
cell	NN	cell
proliferation	NN	proliferation
,	,	,
fibrogenesis	NN	fibrogenesis
,	,	,
and	CC	and
cancer	NN	cancer
susceptibility	NN	susceptibility
,	,	,
possibly	RB	possibly
representing	VBG	represent
a	DT	a
molecular	JJ	molecular
signature	NN	signature
in	IN	in
NAFLD	NNP	NAFLD
during	IN	during
IR	NNP	IR
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
miR-101-3p	CD	miR-101-3p
overexpression	NN	overexpression
in	IN	in
HepG2	NNP	HepG2
and	CC	and
LX-2	NNP	LX-2
reduced	VBD	reduce
proliferation	NN	proliferation
,	,	,
migration	NN	migration
,	,	,
and	CC	and
invasiveness	NN	invasiveness
,	,	,
regulating	VBG	regulate
pro-fibrotic	JJ	pro-fibrotic
and	CC	and
pro-carcinogenic	JJ	pro-carcinogenic
markers	NNS	marker
.	.	.
</s>
</p>
</text>
